Moderna Clinical Trials
Find clinical trials for Moderna. Search for Moderna clinical trials in different cities and states across the United States.
Pfizer/BioNTech & ModernaPROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS
Sponsor:
DHR Health Institute for Research and Development
Location:
Code:
NCT05279365
Conditions
SARS CoV 2 Infection
COVID-19
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Pfizer/BioNTech (BNT162b2)
Moderna
Observational StudyThe Impact of COVID-19 on Maternal and Neonatal Outcomes
Sponsor:
Johns Hopkins University
Location:
Code:
NCT05197621
Conditions
COVID-19
Pregnancy; Infection
Eligibility Criteria
Sex: Female
Age: 14 - 55
Healthy Volunteers: Accepted
Interventions
mRNA COVID-19 vaccine (Pfizer or Moderna)
Observational StudyCovid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
Sponsor:
Well- Konnect Healthcare Services and Research Firm
Location:
Code:
NCT06441955
Conditions
COVID-19, Long Haul
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Interventions
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Physiological Evaluation
Moderna COVID-19 Vaccine
Biopsychological
Behavioral (e.g., Psychotherapy, Lifestyle Counseling)
mRNA-3927A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
Sponsor:
Moderna
Location:
Code:
NCT05130437
Conditions
Propionic Acidemia
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Interventions
mRNA-3927
mRNA-1083A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
Sponsor:
Moderna
Location:
Code:
NCT06864143
Conditions
Influenza
SARS-CoV-2
Eligibility Criteria
Sex: All
Age: 18 - 64
Healthy Volunteers: Accepted
Interventions
mRNA-1083 Composition 1 Dose A Lot A
mRNA-1083 Composition 1 Dose A Lot B
mRNA-1083 Composition 1 Dose B
mRNA-1083 Composition 1 Dose C
mRNA-1083 Composition 2 Dose A
mRNA COVID-19 VaccinesA Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
Sponsor:
Moderna
Location:
Code:
NCT05436834
Conditions
SARS-CoV-2
Eligibility Criteria
Sex: All
Age: 6 - 5
Healthy Volunteers: Accepted
Interventions
mRNA-1273.214
mRNA-1273.815
mRNA-4106 & Immune Checkpoint BlockadeA Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors
Sponsor:
Moderna
Location:
Code:
NCT06880549
Conditions
Advanced Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
mRNA-4106
Nivolumab/Relatlimab
mRNA-3705A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia
Sponsor:
Moderna
Location:
Code:
NCT04899310
Conditions
Methylmalonic Acidemia
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Interventions
mRNA-3705
mRNA-4157 & PembrolizumabAn Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
Sponsor:
Moderna
Location:
Code:
NCT03897881
Conditions
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
mRNA-4157
Pembrolizumab
mRNA-1647A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
Sponsor:
Moderna
Location:
Code:
NCT05683457
Conditions
Cytomegalovirus Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
mRNA-1647
Placebo